DNA hypermethylation of IRX4 is a frequent event that may confer growth advantage to pancreatic cancer cells

被引：3
|
作者：
Chakma, Kanchan [1 ]
Gu, Zhaodi [2 ]
Motoi, Fuyuhiko [3 ]
Unno, Michiaki [3 ]
Horii, Akira [2 ]
Fukushige, Shinichi [2 ]
机构：
[1] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh
[2] Tohoku Univ, Dept Mol Pathol, Sch Med, Sendai, Miyagi, Japan
[3] Tohoku Univ, Dept Gastroenterol Surg, Sch Med, Sendai, Miyagi, Japan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-821
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
821
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IRX4, a hypermethylated gene in pancreatic cancer, regulates expression of a subset of cancer-related genes
    Fukushige, Shinichi
    Gu, Zhaodi
    Horii, Akira
    CANCER SCIENCE, 2018, 109 : 1171 - 1171
  • [2] Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer
    Norrie, MWA
    Hawkins, NJ
    Todd, AV
    Meagher, AP
    O'Connor, TW
    Ward, RL
    JOURNAL OF SURGICAL ONCOLOGY, 2003, 84 (03) : 143 - 150
  • [3] DNA hypermethylation at the D17S5 locus is not a frequent event in human urothelial cancer
    Bernués, M
    Casadevall, C
    Caballín, MR
    Egozcue, J
    Miró, R
    BJU INTERNATIONAL, 2002, 90 (03) : 332 - 335
  • [4] IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility
    Hai Ha Nguyen
    Takata, Ryo
    Akamatsu, Shusuke
    Shigemizu, Daichi
    Tsunoda, Tatsuhiko
    Furihata, Mutsuo
    Takahashi, Atsushi
    Kubo, Michiaki
    Kamatani, Naoyuki
    Ogawa, Osamu
    Fujioka, Tomoaki
    Nakamura, Yusuke
    Nakagawa, Hidewaki
    HUMAN MOLECULAR GENETICS, 2012, 21 (09) : 2076 - 2085
  • [5] Cyclooxygenase-2 Confers Growth Advantage to Syngeneic Pancreatic Cancer Cells
    Takahashi, Hiroki
    Li, Aihua
    Dawson, David W.
    Hines, Oscar Joe
    Reber, Howard A.
    Eibl, Guido
    PANCREAS, 2011, 40 (03) : 453 - 459
  • [6] Expression of COX-2 confers growth advantage to pancreatic cancer cells
    Li, Aihua
    Hasan, Sascha
    Angst, Eliane
    Reber, Howard A.
    Hines, Oscar J.
    Eibl, Guido
    GASTROENTEROLOGY, 2008, 134 (04) : A452 - A452
  • [7] GROWTH ADVANTAGE OF COX-2 EXPRESSING PANCREATIC CANCER CELLS IN VITRO AND IN VIVO
    Li, A.
    Hasan, S.
    Angst, E.
    Park, J.
    Reber, H. A.
    Hines, O. J.
    Eibl, G.
    PANCREAS, 2008, 37 (04) : 480 - 480
  • [8] Pancreatic Drainage in Chronic Calcific Pancreatitis May Not Confer Protection Against Pancreatic Cancer But offers a Definite Survival Advantage When Compared With Patients Who Have Not Undergone Any Drainage Procedures
    George, Jeffey
    Gopalakrishna, Rajesh
    Panicker, Suprabha
    Venu, Rama P.
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB274 - AB274
  • [9] EphB4 regulates the growth and migration of pancreatic cancer cells
    Li, Man
    Zhao, Jinbo
    Qiao, Jinjing
    Song, Chen
    Zhao, Zuowei
    TUMOR BIOLOGY, 2014, 35 (07) : 6855 - 6859
  • [10] 1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
    Jia, Zhirong
    Zhang, Yameng
    Yan, Aiwen
    Wang, Meisa
    Han, Qiushuang
    Wang, Kaiwei
    Wang, Jie
    Qiao, Chen
    Pan, Zhenzhen
    Chen, Chuansheng
    Hu, Dong
    Ding, Xuansheng
    CELL DEATH & DISEASE, 2020, 11 (08)
12345